News about PaperPanda, Open Access, and Research
Editor’s Note (12/21/21): This article is being showcased in a special collection about equity in health care that was made possible by the support of Takeda Pharmaceuticals. The article was published independently and without sponsorship. Recently, one of my patients borrowed money from a loan shark just to get a private taxi to the hospital. … Read more
During the early months of the COVID-19 pandemic, Jay Van Bavel, a psychologist at New York University, wanted to identify the social factors that best predict a person’s support for public-health measures, such as physical distancing or closing restaurants. He had a handful of collaborators ready to collect survey data. But because the pandemic was … Read more
Editor’s Note (12/21/21): This article is being showcased in a special collection about equity in health care that was made possible by the support of Takeda. The article was published independently and without sponsorship. COVID-19 has cut a jarring and unequal path across the U.S. The disease has disproportionately harmed and killed people of color. … Read more
Editor’s Note (12/21/21): This article is being showcased in a special collection about equity in health care that was made possible by the support of Takeda. The article was published independently and without sponsorship. The past few days have been awash with news of the emergence of the latest concerning variant of the virus behind … Read more
A few days ago, New York Mayor Bill de Blasio announced that the city would provide 500,000 free at-home COVID tests to city residents through community centers. This step toward more equitable testing came days after a heated exchange between White House spokesperson Jen Psaki and a National Public Radio reporter in which Psaki scoffed … Read more
It has been less than four weeks since the announcement that a mutation-laden coronavirus variant had been discovered in southern Africa. Since then, dozens of countries around the world have reported Omicron cases—including a worrying number of infections in people who have either been vaccinated or experienced previous SARS-CoV-2 infections. But as political leaders and public-health officials try to … Read more
The following essay is reprinted with permission from The Conversation, an online publication covering the latest research. As winter begins and the holidays are in full swing, the COVID-19 pandemic has entered another worrying phase. Emergence of the omicron variant, along with increasing rates of infections, have left many people unsure about their holiday plans. On Dec. … Read more
Opinion The extra shot doesn’t mean that vaccines are ineffective; our bodies just need a reminder | The Coronavirus Outbreak, A man is given a COVID-19 booster shot at Stony Brook University Research and Development Park in Stony Brook, New York on Nov. 17, 2021. Credit: Steve Pfost/Newsday/Getty ImagesOpinion The extra shot doesn’t mean that … Read more
The fast-spreading Omicron SARS-CoV-2 variant is highly likely to compromise some of the protection from vaccines, suggest the first laboratory studies of Omicron’s ability to evade immunity. But the preliminary results—released overnight by teams in South Africa, Germany, and Sweden, as well as the Pfizer-BioNtech collaboration—hint that protection conferred by existing COVID-19 vaccines won’t be … Read more